Turn Therapeutics (TTRX) Other Non-Current Assets (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Other Non-Current Assets of $6.2 million in Q1 2026, up 4.01% quarter-over-quarter from $6.0 million in Q4 2025.
Turn Therapeutics (TTRX) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Turn Therapeutics' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (changed N/A YoY), while the FY2025 annual figure was $6.0 million, up 69306.01% from the prior year.
- Other Non-Current Assets was $6.2 million for Q1 2026 at Turn Therapeutics, up from $6.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.2 million in Q1 2026 to a low of $8582.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $3.0 million across 3 years, with a median of $3.0 million in 2024.
- Biggest YoY gain for Other Non-Current Assets was 69306.01% in 2025; the steepest drop was 69306.01% in 2025.
- A 3-year view of Other Non-Current Assets shows it stood at $8582.0 in 2024, then soared by 69306.01% to $6.0 million in 2025, then advanced by 4.01% to $6.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $6.2 million (Q1 2026), $6.0 million (Q4 2025), and $8582.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Turn Therapeutics | 178.62 Mn | 178.62 Mn | - | 6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.20 Mn |
| Dec 31, 2025 | 5.96 Mn |
| Sep 30, 2025 | 8,582.00 |
| Dec 31, 2024 | 8,582.00 |